BRD4 connects enhancer remodeling to senescence immune surveillance Journal Article


Authors: Tasdemir, N.; Banito, A.; Roe, J. S.; Alonso-Curbelo, D.; Camiolo, M.; Tschaharganeh, D. F.; Huang, C. H.; Aksoy, O.; Bolden, J. E.; Chen, C. C.; Fennell, M.; Thapar, V.; Chicas, A.; Vakoc, C. R.; Lowe, S. W.
Article Title: BRD4 connects enhancer remodeling to senescence immune surveillance
Abstract: Oncogene-induced senescence is a potent barrier to tumorigenesis that limits cellular expansion following certain oncogenic events. Senescent cells display a repressive chromatin configuration thought to stably silence proliferation-promoting genes while simultaneously activating an unusual form of immune surveillance involving a secretory program referred to as the senescence-associated secretory phenotype (SASP). Here, we demonstrate that senescence also involves a global remodeling of the enhancer landscape with recruitment of the chromatin reader BRD4 to newly activated super-enhancers adjacent to key SASP genes. Transcriptional profiling and functional studies indicate that BRD4 is required for the SASP and downstream paracrine signaling. Consequently, BRD4 inhibition disrupts immune cell-mediated targeting and elimination of premalignant senescent cells in vitro and in vivo. Our results identify a critical role for BRD4-bound super-enhancers in senescence immune surveillance and in the proper execution of a tumor-suppressive program. SIGNIFICANCE: This study reveals how cells undergoing oncogene-induced senescence acquire a distinctive enhancer landscape that includes formation of super-enhancers adjacent to immune-modulatory genes required for paracrine immune activation. This process links BRD4 and super-enhancers to a tumor-suppressive immune surveillance program that can be disrupted by small molecule inhibitors of the bromo and extra terminal domain family of proteins. © 2016 American Association for Cancer Research.
Journal Title: Cancer Discovery
Volume: 6
Issue: 6
ISSN: 2159-8274
Publisher: American Association for Cancer Research  
Date Published: 2016-06-01
Start Page: 612
End Page: 629
Language: English
DOI: 10.1158/2159-8290.cd-16-0217
PROVIDER: scopus
PMCID: PMC4893996
PUBMED: 27099234
DOI/URL:
Notes: Article -- Export Date: 2 March 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics